Anusha Shirwaikar Thomas

6PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityFood properties (incl. characteristics and health benefits)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 12, 2025
The Impact of Fecal Diversion on Immune Checkpoint Inhibitor Adverse Gastrointestinal Toxicities.

Saltenat Moghaddam Adames, Sidra Naz, Jianliang Dai

|May 14, 2025
Autoimmune Pancreatitis: A Review.

Varun Vemulapalli, Cristina Natha, Anusha Shirwaikar Thomas

|Apr 17, 2025
The Role of Vitamin D in Gastrointestinal Homeostasis and Gut Inflammation.

Varun Vemulapalli, Anusha Shirwaikar Thomas

|Jan 11, 2025
Predictive Value of FDG Uptake on PET for Future Immune Checkpoint Inhibitor-Mediated Colitis: A Case Series.

Malek Shatila, Kei Takigawa, Yang Lu

|Nov 14, 2024
Systematic review of immune checkpoint inhibitor-related gastrointestinal, hepatobiliary, and pancreatic adverse events.

Malek Shatila, Hao Chi Zhang, Anusha Shirwaikar Thomas

|May 25, 2024
Outcomes of Budesonide as a Treatment Option for Immune Checkpoint Inhibitor-Related Colitis in Patients with Cancer.

Antonio Pizuorno Machado, Abdullah Salim Shaikh, Alice Saji

Pageof 1